Autoantibodies to alpha-synuclein in inherited Parkinson's disease. - Wikidata - awgldk - TriplyDB

Autoantibodies to alpha-synuclein in inherited Parkinson's disease.

Autoantibodies to alpha-synuclein in inherited Parkinson's disease.

http://www.wikidata.org/entity/Q35159805

about

Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity Prion peptide uptake in microglial cells--the effect of naturally occurring autoantibodies against prion protein Decrease in plasma levels of α-synuclein is evident in patients with Parkinson's disease after elimination of heterophilic antibody interference Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease.Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies.α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.Autoantigen discovery with a synthetic human peptidome.Targeting progressive neuroaxonal injury: lessons from multiple sclerosis.Neuromelanin is an immune stimulator for dendritic cells in vitro.α-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays.Altered serum IgG levels to α-synuclein in dementia with Lewy bodies and Alzheimer's disease.Comparable autoantibody serum levels against amyloid- and inflammation-associated proteins in Parkinson's disease patients and controls.γ-Synuclein antibodies have neuroprotective potential on neuroretinal cells via proteins of the mitochondrial apoptosis pathway.Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review.Chaperoned amyloid proteins for immune manipulation: α-Synuclein/Hsp70 shifts immunity toward a modulatory phenotype Dimebon slows progression of proteinopathy in γ-synuclein transgenic mice.Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.Blood biomarker for Parkinson disease: peptoids.Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease Human serum antibodies against EBV latent membrane protein 1 cross-react with α-synuclein.Parkinson's disease and enhanced inflammatory response.Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission.Immunological features of alpha-synuclein in Parkinson's disease.Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies.Parkinson's disease, autoimmunity, and olfaction.Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.Inflammation and adaptive immunity in Parkinson's disease.Autoimmunity, dendritic cells and relevance for Parkinson's disease.Pathogenic and physiological autoantibodies in the central nervous system.New concepts in the early and preclinical detection of Parkinson's disease: therapeutic implications.The role of inflammation in sporadic and familial Parkinson's disease.The role of innate and adaptive immunity in Parkinson's disease.Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders.Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+ T-cells.Immunology, autoimmunity, and autoantibodies in Parkinson's disease.α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology.Late stages of hematopoiesis and B cell lymphopoiesis are regulated by α-synuclein, a key player in Parkinson's disease.Protein clearance mechanisms of alpha-synuclein and amyloid-Beta in lewy body disorders.

P2860

Q27015811-29F10E63-0C56-4CD3-B462-6729148C4230 Q27027973-9EF32732-572B-4046-88FC-C9A706C9F169 Q28534389-72BECDED-C356-475B-A173-EA476EE46E85 Q28545821-45BBDCAB-302D-4DD1-9AF4-46132EB0A459 Q33526342-EBA41B62-DAFE-4E7D-822B-9E6FCF4517ED Q33776552-7A374F8A-BC3E-478B-B602-A646769561F2 Q33889446-453B642F-E705-4A4E-AC9D-05A33C63F307 Q33908182-96585E8B-5588-445E-9339-237CE6260A93 Q34003724-8BE37459-A62E-47AB-A3F3-EEEAFC99DA88 Q34074838-E09AECC0-977F-4AE6-8E33-152CD0047EAD Q34533573-32461324-AF59-40DB-9AD1-8E56081F921D Q34627859-5FD33A68-A496-4211-8E08-152CD93DD8E1 Q34760606-84868A74-E2DA-46B2-AD50-CAB504871E0C Q35106166-97120F77-3924-4F9B-9CD7-83BC34A4E705 Q35111136-E57A99E8-A619-457F-87B2-226051EB057A Q35139572-077CB4CD-E84B-40F0-8BF2-6E6C26C98127 Q35285839-D59866FF-EB7E-438A-8FE2-C0CE7FCA75EC Q35957568-66BBA8AE-C864-482E-9A43-FFB65A02109F Q36179280-4D6C9EA7-6CDE-4647-8E55-3370DC4B5CDA Q36182485-0A901F2B-C3E1-4976-9C3D-AA4BBB69DA12 Q36462680-1F1748E3-3B2A-4183-A7D2-98EE43D8A8BF Q36894433-16C95B58-0E51-43C0-AE57-0614E0EAAD0A Q37071201-61CB0B2D-669A-4F60-8943-1224D877D170 Q37117527-FC1428F9-F381-4C6F-8F6B-AA48100018B3 Q37232067-7491DC82-0CE4-4283-B78C-5E7AD477E1F8 Q37614686-A5325732-678C-44EA-BF22-8EF0C9DA18FD Q37633575-3368AA3A-593E-4020-AA0D-1133DD619C3A Q37881948-023B5BEF-4017-4977-BD84-988BC24481BA Q37982378-9C814E0A-C5CE-4441-80AE-F5195077338C Q38018827-108ACA4D-0676-4848-B3B5-D257885F0FB4 Q38020957-E4DE5D79-75CA-4604-A62E-DB81E8C15E5D Q38067141-FC6841D8-ACCB-4397-977E-7436BD883889 Q38105903-DBB67BE9-7A7C-4599-9AC7-04F10BA2D07A Q38166155-555F6F0C-7845-4C6D-AFA2-3F1DA2D22748 Q38184645-3C647B56-2712-4885-A5C2-52F992448E5D Q38505120-91B37786-5051-46D6-8565-23F814DC2631 Q39607978-9A9DAECE-4188-48D5-A9B8-8E284CF75AFE Q39972820-6C38EEE4-3AD4-40CE-92C0-177BDF82F6B3 Q40834797-4E29DC85-C02A-4ADA-B4A9-7439260C2618 Q41597801-EE0653AD-131C-4CFA-A6B5-12E62DA9303B

P2860

Autoantibodies to alpha-synuclein in inherited Parkinson's disease.

http://www.wikidata.org/entity/Q35159805

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Autoantibodies to alpha-synuclein in inherited Parkinson's disease.

@ast

Autoantibodies to alpha-synuclein in inherited Parkinson's disease.

@en

type

label

Autoantibodies to alpha-synuclein in inherited Parkinson's disease.

@ast

Autoantibodies to alpha-synuclein in inherited Parkinson's disease.

@en

prefLabel

Autoantibodies to alpha-synuclein in inherited Parkinson's disease.

@ast

Autoantibodies to alpha-synuclein in inherited Parkinson's disease.

@en

P1433

Q35159805-1FA41152-D3C9-4986-B337-5100E2B69677

P1476

Q35159805-B76E768B-D806-4E0B-AC20-232E6D7CD158

P2093

Q35159805-4FB870DB-F1B7-4B7D-AE56-874BEED583A7

Q35159805-5AA4F0B3-3273-45CF-8DDA-AB3DC73134B2

Q35159805-758ACB88-04FA-48F9-A3B5-7918A5F6645B

Q35159805-7EE4AA01-A34A-43DB-849F-C805ED78B42F

Q35159805-A545F882-30A4-4C09-A319-48F535B7B4FB

Q35159805-B57D932F-1E20-4B73-8D24-1A71184A2048

Q35159805-E2CEC0BF-F9D2-4100-BDD4-F18BB99F816A

P2860

Q35159805-14BA27F6-3C86-45CD-A8B4-4AC029FBFA27

Q35159805-1537A4B7-DD85-4555-979D-EF8A93DBC3E0

Q35159805-18BBAE1B-0C59-44CD-B81F-950837FC9D07

Q35159805-1AA096E4-958F-452F-91ED-76AD88B0F5C8

Q35159805-1C88F661-CA03-4448-8DEF-4D39E4D5BDDA

Q35159805-1CDE7CAE-3D83-4795-8D12-8E764B78D60B

Q35159805-22B62F7D-7454-4644-ADC4-762FA209714B

Q35159805-3BBB66DD-4319-4DC6-B2F8-D389D9F8D0AF

Q35159805-45186948-190A-4133-B0BE-EC0A7282D13B

Q35159805-498B5A91-B703-4692-A38E-DED12762BFB5

P304

Q35159805-24DC296B-1B07-45FF-8B90-E208157FA8EB

P31

Q35159805-C3B81137-8373-4BBA-8A3E-AB9D60358819

P356

Q35159805-84AF6111-300B-409F-8AF1-760C27B1E3EC

P407

Q35159805-4C159C28-3D64-4126-9C2D-800F840EFAC1

P433

Q35159805-6BD59C16-B6F7-4168-904C-6D64F474A639

P478

Q35159805-1407B9C1-149B-496E-8781-BF277EEA9E87

P50

Q35159805-D9ADD1FF-F95B-43A7-8C53-75ABB52F32FA

P577

Q35159805-4D96B608-11C6-439F-B60B-7807B4844AEE

P5875

Q35159805-D3A01CF2-B615-4017-984A-C022072DC014

P698

Q35159805-94455054-1E6B-4876-A4A6-A07B780A9130

P921

Q35159805-64EE22BE-5E50-4687-9365-3F60B270C4C6

Q35159805-7DF85BA5-A809-4BA1-8CCD-6F0F7955F019

Q35159805-D8E1D345-2D89-45B0-BD32-2B8374120D2E

P932

Q35159805-E10FA707-119B-45AB-BA65-362D0F7F1E2E

P356

J.1471-4159.2006.04365.X

P1433

Journal of Neurochemistry

P1476

Autoantibodies to alpha-synuclein in inherited Parkinson's disease

@en

P2093

Alexandros Papadimitriou

http://www.w3.org/2001/XMLSchema#string

Anastasios Kalofoutis

http://www.w3.org/2001/XMLSchema#string

Angeliki Papapanagiotou

http://www.w3.org/2001/XMLSchema#string

Georgia Xiromerisiou

http://www.w3.org/2001/XMLSchema#string

Georgios M Hadjigeorgiou

http://www.w3.org/2001/XMLSchema#string

Katerina K Papachroni

http://www.w3.org/2001/XMLSchema#string

Natalia Ninkina

http://www.w3.org/2001/XMLSchema#string

P2860

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease

Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration

Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system

Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism.

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.

The role of costimulation in autoimmune demyelination.

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy.

Neuroinflammatory processes in Parkinson's disease.

The role of alpha-synuclein in Parkinson's disease: insights from animal models.

Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease

P304

749-756

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1471-4159.2006.04365.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Vladimir Buchman

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6380982

http://www.w3.org/2001/XMLSchema#string

P698

17448146

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3154646

http://www.w3.org/2001/XMLSchema#string